Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 6 Thymoma 1 Neoplasm Metastasis 1 Esophageal Neoplasms 1 Clinical Stage III Gastric Cancer AJCC v8 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Gastric Cancer 1 Adenocarcinoma Of Esophagus 1 Adenocarcinoma 1

Interventions

130-nm albumin-bound paclitaxel 2 selinexor 1 pembrolizumab 1 isophosphamide mustard 1 epacadostat 1 Sunitinib 1 Ramucirumab 1 Radiotherapy 1 Radiation Dose Hypofractionation 1 Paclitaxel 1 Leucovorin 1 Histocompatibility Testing 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Epirubicin 1 Cyclophosphamide 1 Cisplatin 1 Chemoradiotherapy 1 Carboplatin 1 68Ga-pentixafor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Thymoma × Ramucirumab × Clear all

NCT03921671 2024-05-29

RELEVENT

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown

Neoplasm Metastasis, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡